-
US indices finished yesterday’s trading higher. S&P 500 gained 0.65%, Dow Jones added 0.53% and Nasdaq jumped 1.05%. Russell 2000 gained 0.31%
-
Upbeat moods dominated during the Asian session as well. Nikkei gained 0.5%, S&P/ASX 200 added 0.8%, Kospi traded 0.7% higher and indices from China advanced
-
DAX futures point to a slightly higher opening of the European session
-
Italy, France and Germany suspended use of AstraZeneca vaccine due to side effects. On the other hand, Thailand reversed decision to suspend the vaccine while Canada is about to approve AstraZeneca product for those above 65 years old
-
According to Australian media, United States will not improve its relationship with China until Asian country stops economic harassment of Australia
-
RBA Minutes showed that the Bank expects no rate hike until at least 2024
-
Japan will make a decision on Thursday whether to lift state of emergency or not
-
BoJ Governor Kuroda said that there is no need to change the yield curve control framework. He also reminded that asset prices are not a part of BoJ mandate
-
Bitcoin dropped below $55,000
-
Agricultural goods and precious metals gain. Oil trades lower
-
AUD and CHF are the best performing major currencies while GBP and NZD lag the most
EURUSD has managed to recover slightly last week but declines were resumed this week. Main currency pair is testing a support zone at 1.1900, that is being strengthened by the 200-session moving average (purple line). Source: xStation5
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
